Table 1. Biological Drug CDMO Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Biological Drug CDMO Market Restraints

Table 3. Biological Drug CDMO Market Trends

Table 4. Biological Drug CDMO Industry Policy

Table 5. Global Biological Drug CDMO Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Biological Drug CDMO Revenue Market Share by Company (2018-2023)

Table 7. Global Biological Drug CDMO Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Biological Drug CDMO Mergers & Acquisitions, Expansion Plans

Table 9. Global Biological Drug CDMO Manufacturers Product Type

Table 10. China Biological Drug CDMO Revenue by Company (2018-2023) & (US$ million)

Table 11. China Biological Drug CDMO Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Biological Drug CDMO Upstream (Raw Materials)

Table 13. Global Biological Drug CDMO Typical Customers

Table 14. Biological Drug CDMO Typical Distributors

Table 15. By Type, Global Biological Drug CDMO Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Biological Drug CDMO Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Biological Drug CDMO Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Biological Drug CDMO Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Biological Drug CDMO Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Biological Drug CDMO Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Biological Drug CDMO Revenue Market Share, 2018-2029

Table 22. Samsung Biologics Company Information, Head Office, Market Area and Industry Position

Table 23. Samsung Biologics Company Profile and Main Business

Table 24. Samsung Biologics Biological Drug CDMO Models, Specifications and Application

Table 25. Samsung Biologics Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 26. Samsung Biologics Recent Developments

Table 27. Lonza Company Information, Head Office, Market Area and Industry Position

Table 28. Lonza Company Profile and Main Business

Table 29. Lonza Biological Drug CDMO Models, Specifications and Application

Table 30. Lonza Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 31. Lonza Recent Developments

Table 32. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position

Table 33. Boehringer Ingelheim Company Profile and Main Business

Table 34. Boehringer Ingelheim Biological Drug CDMO Models, Specifications and Application

Table 35. Boehringer Ingelheim Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 36. Boehringer Ingelheim Recent Developments

Table 37. Catalent Company Information, Head Office, Market Area and Industry Position

Table 38. Catalent Company Profile and Main Business

Table 39. Catalent Biological Drug CDMO Models, Specifications and Application

Table 40. Catalent Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 41. Catalent Recent Developments

Table 42. BioCentriq Company Information, Head Office, Market Area and Industry Position

Table 43. BioCentriq Company Profile and Main Business

Table 44. BioCentriq Biological Drug CDMO Models, Specifications and Application

Table 45. BioCentriq Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 46. BioCentriq Recent Developments

Table 47. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, Market Area and Industry Position

Table 48. FUJIFILM Diosynth Biotechnologies Company Profile and Main Business

Table 49. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Models, Specifications and Application

Table 50. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 51. FUJIFILM Diosynth Biotechnologies Recent Developments

Table 52. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

Table 53. Thermo Fisher Scientific Company Profile and Main Business

Table 54. Thermo Fisher Scientific Biological Drug CDMO Models, Specifications and Application

Table 55. Thermo Fisher Scientific Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 56. Thermo Fisher Scientific Recent Developments

Table 57. Recipharm Company Information, Head Office, Market Area and Industry Position

Table 58. Recipharm Company Profile and Main Business

Table 59. Recipharm Biological Drug CDMO Models, Specifications and Application

Table 60. Recipharm Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 61. Recipharm Recent Developments

Table 62. Delpharm Company Information, Head Office, Market Area and Industry Position

Table 63. Delpharm Company Profile and Main Business

Table 64. Delpharm Biological Drug CDMO Models, Specifications and Application

Table 65. Delpharm Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 66. Delpharm Recent Developments

Table 67. Aenova Company Information, Head Office, Market Area and Industry Position

Table 68. Aenova Company Profile and Main Business

Table 69. Aenova Biological Drug CDMO Models, Specifications and Application

Table 70. Aenova Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 71. Aenova Recent Developments

Table 72. Siegfried Company Information, Head Office, Market Area and Industry Position

Table 73. Siegfried Company Profile and Main Business

Table 74. Siegfried Biological Drug CDMO Models, Specifications and Application

Table 75. Siegfried Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 76. Siegfried Recent Developments

Table 77. WuXi Biologics Company Information, Head Office, Market Area and Industry Position

Table 78. WuXi Biologics Company Profile and Main Business

Table 79. WuXi Biologics Biological Drug CDMO Models, Specifications and Application

Table 80. WuXi Biologics Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 81. WuXi Biologics Recent Developments

Table 82. Obio Technology Company Information, Head Office, Market Area and Industry Position

Table 83. Obio Technology Company Profile and Main Business

Table 84. Obio Technology Biological Drug CDMO Models, Specifications and Application

Table 85. Obio Technology Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 86. Obio Technology Recent Developments

Table 87. Hepalink Company Information, Head Office, Market Area and Industry Position

Table 88. Hepalink Company Profile and Main Business

Table 89. Hepalink Biological Drug CDMO Models, Specifications and Application

Table 90. Hepalink Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 91. Hepalink Recent Developments

Table 92. Pharmaron Company Information, Head Office, Market Area and Industry Position

Table 93. Pharmaron Company Profile and Main Business

Table 94. Pharmaron Biological Drug CDMO Models, Specifications and Application

Table 95. Pharmaron Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 96. Pharmaron Recent Developments

Table 97. ChemPartner Company Information, Head Office, Market Area and Industry Position

Table 98. ChemPartner Company Profile and Main Business

Table 99. ChemPartner Biological Drug CDMO Models, Specifications and Application

Table 100. ChemPartner Biological Drug CDMO Revenue and Gross Margin, 2018-2023

Table 101. ChemPartner Recent Developments

List of Figure

Figure 1. Biological Drug CDMO Picture

Figure 2. Global Biological Drug CDMO Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Biological Drug CDMO Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Biological Drug CDMO Market Share of Global

Figure 5. Global Biological Drug CDMO Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Biological Drug CDMO Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Biological Drug CDMO Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Biological Drug CDMO Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Biological Drug CDMO Industry Chain

Figure 10. Innovative Drug

Figure 11. Listed Patent Drugs

Figure 12. Biosimilar

Figure 13. By Type, Global Biological Drug CDMO Revenue, 2018-2029, US$ Million

Figure 14. By Type, Global Biological Drug CDMO Revenue Market Share, 2018-2029

Figure 15. Pharmaceutical Company

Figure 16. Biotechnology Company

Figure 17. By Application, Global Biological Drug CDMO Revenue, 2018-2029, US$ Million

Figure 18. By Application, Global Biological Drug CDMO Revenue Market Share, 2018-2029

Figure 19. By Region, Global Biological Drug CDMO Revenue Market Share, 2018-2029

Figure 20. North America Biological Drug CDMO Revenue & Forecasts, 2018-2029, US$ Million

Figure 21. By Country, North America Biological Drug CDMO Revenue Market Share, 2018-2023

Figure 22. Europe Biological Drug CDMO Revenue & Forecasts, 2018-2029, US$ Million

Figure 23. By Country, Europe Biological Drug CDMO Revenue Market Share, 2018-2023

Figure 24. Asia Pacific Biological Drug CDMO Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country/Region, Asia Pacific Biological Drug CDMO Revenue Market Share, 2018-2023

Figure 26. South America Biological Drug CDMO Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country, South America Biological Drug CDMO Revenue Market Share, 2018-2023

Figure 28. Middle East & Africa Biological Drug CDMO Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. U.S. Biological Drug CDMO Revenue, 2018-2029, (US$ Million)

Figure 30. By Company, U.S. Biological Drug CDMO Market Share, 2018-2023

Figure 31. By Type, U.S. Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 32. By Application, U.S. Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 33. Europe Biological Drug CDMO Revenue, 2018-2029, (US$ Million)

Figure 34. By Company, Europe Biological Drug CDMO Market Share, 2018-2023

Figure 35. By Type, Europe Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 36. By Application, Europe Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 37. China Biological Drug CDMO Revenue, 2018-2029, (US$ Million)

Figure 38. By Company, China Biological Drug CDMO Market Share, 2018-2023

Figure 39. By Type, China Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 40. By Application, China Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 41. Japan Biological Drug CDMO Revenue, 2018-2029, (US$ Million)

Figure 42. By Company, Japan Biological Drug CDMO Market Share, 2018-2023

Figure 43. By Type, Japan Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 44. By Application, Japan Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 45. South Korea Biological Drug CDMO Revenue, 2018-2029, (US$ Million)

Figure 46. By Company, South Korea Biological Drug CDMO Market Share, 2018-2023

Figure 47. By Type, South Korea Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 48. By Application, South Korea Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 49. Southeast Asia Biological Drug CDMO Revenue, 2018-2029, (US$ Million)

Figure 50. By Company, Southeast Asia Biological Drug CDMO Market Share, 2018-2023

Figure 51. By Type, Southeast Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 52. By Application, Southeast Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 53. India Biological Drug CDMO Revenue, 2018-2029, (US$ Million)

Figure 54. By Company, India Biological Drug CDMO Market Share, 2018-2023

Figure 55. By Type, India Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 56. By Application, India Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 57. Middle East & Asia Biological Drug CDMO Revenue, 2018-2029, (US$ Million)

Figure 58. By Company, Middle East & Asia Biological Drug CDMO Market Share, 2018-2023

Figure 59. By Type, Middle East & Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 60. By Application, Middle East & Asia Biological Drug CDMO Revenue Market Share, 2022 VS 2029

Figure 61. Research Methodology

Figure 62. Breakdown of Primary Interviews

Figure 63. Bottom-up Approaches

Figure 64. Top-down Approaches